Provider Resources WA

07/14/22 Health Advisory: Updated Monkeypox Guidance

Exam room with vitals equipment on wall

Requested actions Washington currently has 16 reported cases of monkeypox, mostly in King County. Early cases were linked to travel but Public Health Seattle–King County announced last week the virus is likely spreading locally.  Monkeypox is rare and not often seen in the United States. It can cause a rash that looks like bumps, blisters 07/14/22 Health Advisory: Updated Monkeypox Guidance

06/24/22 Health Advisory: Updated Monkeypox Guidance

Scientists in lab using microscope

Requested actions Immediately report suspected monkeypox cases to Yakima County Health District. Call the reporting line at 800-535-5016 ext. 541. Consider submitting a suspect monkeypox intake form to help us determine whether to test for monkeypox. Be aware, recent confirmed cases of monkeypox in the United States differ from the classic monkeypox presentation of previous 06/24/22 Health Advisory: Updated Monkeypox Guidance

05/12/22 Health Advisory: FDA Limits Use of Johnson & Johnson COVID-19 Vaccine.

Syringe in vial

Requested actions Background FDA limited the authorized use of J&J to people age 18 years and older: This decision came after FDA analyzed, evaluated and investigated reported cases of TTS after getting J&J. TTS is rare and includes potentially life-threatening blood clots in combination with low levels of blood platelets. Symptoms typically start 1–2 weeks 05/12/22 Health Advisory: FDA Limits Use of Johnson & Johnson COVID-19 Vaccine.

05/05/22 Health Advisory: Colorado person first U.S. case of H5 bird flu

Black triangle with an exclamation mark in the middle and "Health Advisory" written below. Appearing on yellow background.

A person in Colorado tested positive for avian influenza A(H5N1) virus (H5 bird flu), Colorado Department of Public Health and Environment reported April 28, 2022. Centers for Disease Control and Prevention (CDC) confirmed it is the first U.S. case of H5 bird flu. The person was involved in the culling of poultry with presumptive H5 05/05/22 Health Advisory: Colorado person first U.S. case of H5 bird flu

04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses eligibility for second booster dose of COVID-19 vaccine

hands in blue medical gloves holding a syringe and drawing from a vile

Requested actions Be aware, on April 25, 2022, Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) advisory about the availability and use of recommended COVID-19 therapies. It also advised against using unproven treatments that have known or potential harm. Follow National Institutes of Health (NIH) COVID-19 treatment guidelines and use 04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses eligibility for second booster dose of COVID-19 vaccine

04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses second COVID-19 booster dose eligibility

Ariel shot of someone taking notes or completing paperwork

Requested actions Be aware, on April 25, 2022, Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) advisory about the availability and use of recommended COVID-19 therapies. It also advised against using unproven treatments that have known or potential harm. Follow National Institutes of Health (NIH) COVID-19 treatment guidelines and use 04/27/22 Health Advisory: CDC Treatment Updates and ACIP discusses second COVID-19 booster dose eligibility

04/08/22 Health Advisory: COVID-19 Information for Providers

Female doctor with file in front of them with two other doctors at a microscope in the background.

Requested actions Be aware, on March 29, 2022, Food and Drug Administration (FDA) amended its emergency use authorization (EUA) for Moderna COVID-19 booster dose vaccine. A new multi-dose vial is now available. It has a dark blue cap and a label with a purple border. Doses from this vial are 0.5 mL. Multi-dose vials are 04/08/22 Health Advisory: COVID-19 Information for Providers

03/30/22 Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups

Syringe in vial

Requested actions Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup endorsed Food and Drug Administration’s (FDA’s) emergency use authorization (EUA) of a second booster dose of Pfizer or Moderna COVID-19 vaccines for specific groups. The EUA allows: A second booster dose of Pfizer COVID-19 vaccine at least 03/30/22 Health Advisory: CDC endorses second booster dose of mRNA COVID-19 vaccine for certain groups

03/07/22 Health Advisory: Update on Johnson & Johnson vaccine ordering and guidance for healthcare settings

person wearing white coat and stethoscope writing on a clipboard

Requested actions Be aware, on March 4, Washington State Department of Health (DOH) discontinued ordering Johnson & Johnson COVID-19 vaccine because inventory is very low at Centers for Disease Control and Prevention (CDC) in Washington Immunization Information System (IIS). We encourage providers to post and look for available doses on IIS vaccine advertisement page. Email 03/07/22 Health Advisory: Update on Johnson & Johnson vaccine ordering and guidance for healthcare settings

02/25/22 Health Advisory: COVID-19 Updates for Providers

Four doctors talking as seen from above. Two with white coats and 2 in scrubs.

Requested actions Be aware, on Feb. 22, Centers for Disease Control and Prevention (CDC) revised its COVID-19 vaccine clinical considerations. An 8-week interval between first and second doses of mRNA COVID-19 vaccine (Moderna and Pfizer) may be optimal for males 12–39 years old to reduce risk of myocarditis and increase efficacy. CDC still recommends a 02/25/22 Health Advisory: COVID-19 Updates for Providers